Intelivation Technologies Received FDA Approval for the Golden Isles Pedicle Screw System™

Intelivation Technologies, a medical device company with a cutting-edge spinal implant product portfolio announced today that they have achieved FDA 510(k) Clearance of the Golden Isles Pedicle Screw System™.

The Golden Isles Pedicle Screw System is designed to provide immobilization and stabilization of spinal segments in skeletally mature patients in treating the lumbar and sacral spine. The system is intended for posterior, non-cervical pedicle fixation in skeletally mature patients for treating degenerative disc disease, spondylolisthesis, trauma, deformities as well as pseudoarthrosis and failed previous fusions.

President Amit Sinha remarked, “The modularity of the Golden Isles Pedicle Screw System enables the surgeon greater versatility, efficiency, and visibility to achieve superior patient outcomes for the most difficult degenerative and traumatic procedures.”

CEO Rob Anderson added, “The simplicity of the system along with the strength of the tulip and screw interface is unsurpassed compared to other options that are currently available on the market.”

Golden Isles showcases both standard and reduction tulips along with a comprehensive set of insertion and reduction instruments. The Management Team looks forward to a successful launch during the 36th Annual NASS Meeting in Boston September 29-Ocotber 2, 2021.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.